These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 17139032)

  • 21. Cost-effectiveness of relapse-prevention cognitive therapy for bipolar disorder: 30-month study.
    Lam DH; McCrone P; Wright K; Kerr N
    Br J Psychiatry; 2005 Jun; 186():500-6. PubMed ID: 15928361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are psychological treatments for depression in primary care cost-effective?
    Bosmans JE; van Schaik DJ; de Bruijne MC; van Hout HP; van Marwijk HW; van Tulder MW; Stalman WA
    J Ment Health Policy Econ; 2008 Mar; 11(1):3-15. PubMed ID: 18424872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.
    Camacho EM; Ntais D; Coventry P; Bower P; Lovell K; Chew-Graham C; Baguley C; Gask L; Dickens C; Davies LM
    BMJ Open; 2016 Oct; 6(10):e012514. PubMed ID: 27855101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of a collaborative care program for primary care patients with persistent depression.
    Simon GE; Katon WJ; VonKorff M; Unützer J; Lin EH; Walker EA; Bush T; Rutter C; Ludman E
    Am J Psychiatry; 2001 Oct; 158(10):1638-44. PubMed ID: 11578996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of cognitive behavioral therapy for insomnia comorbid with depression: Analysis of a randomized controlled trial.
    Watanabe N; Furukawa TA; Shimodera S; Katsuki F; Fujita H; Sasaki M; Sado M; Perlis ML
    Psychiatry Clin Neurosci; 2015 Jun; 69(6):335-43. PubMed ID: 25205008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cost-Effectiveness of the Treatment of Depression in Old Age].
    Bock JO; Brettschneider C; Wegener A; Riedel-Heller S; König HH
    Psychiatr Prax; 2015 Jul; 42(5):240-7. PubMed ID: 26101862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depression in adolescents: Study was not a trial of antidepressants.
    Jureidini JN
    BMJ; 2007 Aug; 335(7613):221; author reply 221. PubMed ID: 17673737
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of depression in primary care. Socio-economic status, clinical need and receipt of treatment.
    Weich S; Nazareth I; Morgan L; King M
    Br J Psychiatry; 2007 Aug; 191():164-9. PubMed ID: 17666502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Future unrelated medical costs need to be considered in cost effectiveness analysis.
    van Baal P; Morton A; Meltzer D; Brouwer W
    Eur J Health Econ; 2019 Feb; 20(1):1-5. PubMed ID: 29671143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of an improving access to psychological therapies service.
    Mukuria C; Brazier J; Barkham M; Connell J; Hardy G; Hutten R; Saxon D; Dent-Brown K; Parry G
    Br J Psychiatry; 2013 Mar; 202(3):220-7. PubMed ID: 23307921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of selective serotonin reuptake inhibitors and routine specialist care with and without cognitive behavioural therapy in adolescents with major depression.
    Byford S; Barrett B; Roberts C; Wilkinson P; Dubicka B; Kelvin RG; White L; Ford C; Breen S; Goodyer I
    Br J Psychiatry; 2007 Dec; 191():521-7. PubMed ID: 18055956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Cost Effectiveness of Mental Health Treatment in the Lifetime of Older Adults with HIV in New York City: A Markov Approach.
    DelaCruz JJ; Brennan-Ing M; Kakolyris A; Martinez O
    Pharmacoecon Open; 2021 Jun; 5(2):221-236. PubMed ID: 33165825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence-Based Applications of Combination Psychotherapy and Pharmacotherapy for Depression.
    Dunlop BW
    Focus (Am Psychiatr Publ); 2016 Apr; 14(2):156-173. PubMed ID: 31975799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature Review.
    Kolovos S; Bosmans JE; Riper H; Chevreul K; Coupé VMH; van Tulder MW
    Pharmacoecon Open; 2017 Sep; 1(3):149-165. PubMed ID: 29441493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychotherapy for Major Depressive Disorder and Generalized Anxiety Disorder: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2017; 17(15):1-167. PubMed ID: 29213344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unreliability of putative fMRI biomarkers during emotional face processing.
    Nord CL; Gray A; Charpentier CJ; Robinson OJ; Roiser JP
    Neuroimage; 2017 Aug; 156():119-127. PubMed ID: 28506872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: a systematic review and meta-analysis.
    Hind D; Cotter J; Thake A; Bradburn M; Cooper C; Isaac C; House A
    BMC Psychiatry; 2014 Jan; 14():5. PubMed ID: 24406031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The estimation of utility weights in cost-utility analysis for mental disorders: a systematic review.
    Sonntag M; König HH; Konnopka A
    Pharmacoeconomics; 2013 Dec; 31(12):1131-54. PubMed ID: 24293216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice.
    Kulkarni J; Filia S; Berk L; Filia K; Dodd S; de Castella A; Brnabic AJ; Lowry AJ; Kelin K; Montgomery W; Fitzgerald PB; Berk M
    BMC Psychiatry; 2012 Dec; 12():228. PubMed ID: 23244301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of an adjunctive brief psychodynamic psychotherapy to usual inpatient treatment of depression: rationale and design of a randomized controlled trial.
    Ambresin G; Despland JN; Preisig M; de Roten Y
    BMC Psychiatry; 2012 Oct; 12():182. PubMed ID: 23110608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.